Novo will drop its U.S. list price for its Fiasp by 75% and for Tresiba by 72%, the Danish company said in a release. The new ...

Patients received the FlexPen if they were randomized to the insulin pen group and prescribed any rapid-acting insulin (insulin lispro or insulin aspart) or the combination of 70% insulin aspart ...

Biphasic insulin aspart 30/70 was administered once ... Denmark] and NovoMix 30 FlexPen® 100 IU/ml suspension for injection in a prefilled pen [Novo Nordisk, Bagsværd, Denmark]).

and Fiasp (insulin aspart), by more than 70% starting Jan. 1, 2026. Fiasp's price will be reduced by 75%, making it the same ...